These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [The status of liver transplantation 1992]. Lauchart W Schweiz Rundsch Med Prax; 1992 Aug; 81(34):985-7. PubMed ID: 1529192 [TBL] [Abstract][Full Text] [Related]
4. Perisinusoidal lipocytes and fibrogenesis. Gressner AM Gut; 1994 Oct; 35(10):1331-3. PubMed ID: 7959178 [No Abstract] [Full Text] [Related]
5. Role of replicative senescence in the progression of fibrosis in hepatitis C virus (HCV) recurrence after liver transplantation. Trak-Smayra V; Contreras J; Dondero F; Durand F; Dubois S; Sommacale D; Marcellin P; Belghiti J; Degott C; Paradis V Transplantation; 2004 Jun; 77(11):1755-60. PubMed ID: 15201678 [TBL] [Abstract][Full Text] [Related]
6. [Indications of liver transplantation]. Zhu ZJ; Shen ZY Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):371. PubMed ID: 15225439 [No Abstract] [Full Text] [Related]
7. Pathologic aspects of cirrhosis. A review. Popper H Am J Pathol; 1977 Apr; 87(1):228-64. PubMed ID: 322505 [No Abstract] [Full Text] [Related]
8. Hepatic fibrogenesis and its modulation by growth factors. Lissoos TW; Beno DW; Davis BH J Pediatr Gastroenterol Nutr; 1992 Oct; 15(3):225-31. PubMed ID: 1432458 [No Abstract] [Full Text] [Related]
9. Angiotensin II antagonists in patients with recurrent hepatitis C virus infection after liver transplantation. Cholongitas E; Vibhakorn S; Lodato F; Burroughs AK Liver Int; 2010 Feb; 30(2):334-5. PubMed ID: 19515217 [No Abstract] [Full Text] [Related]
10. Hepatic stellate cell immunodetection and cirrhotic evolution of viral hepatitis in liver allografts. Guido M; Rugge M; Leandro G; Fiel IM; Thung SN Hepatology; 1997 Aug; 26(2):310-4. PubMed ID: 9252139 [TBL] [Abstract][Full Text] [Related]
11. Long-term survival and complications after orthotopic liver transplantation for postnecrotic cirrhosis. Lohmann R; Langrehr JM; Neuhaus R; Raakow R; Bechstein WO; Neuhaus P Transplant Proc; 2000 May; 32(3):599. PubMed ID: 10812131 [No Abstract] [Full Text] [Related]
12. [Reinfection of HBV and its possible mechanism in patients with liver-transplantation]. Fang Q; Zhao LS; Zhou TY; Liu J; Liu L; Tang H; Lu SC Zhonghua Gan Zang Bing Za Zhi; 2005 Mar; 13(3):225-7. PubMed ID: 15760564 [No Abstract] [Full Text] [Related]
13. Hepatitis G virus and post-transplantation hepatitis. Belli LS; Idéo G; Silini E N Engl J Med; 1996 Oct; 335(18):1394-5. PubMed ID: 8927067 [No Abstract] [Full Text] [Related]
14. Postnecrotic cirrhosis following varicella hepatitis in a liver transplant patient. Alonso EM; Fox AS; Franklin WA; Whitington PF Transplantation; 1990 Mar; 49(3):650-3. PubMed ID: 2316023 [No Abstract] [Full Text] [Related]
16. Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis B immune globulin posttransplant. Tchervenkov JI; Tector AJ; Barkun JS; Sherker A; Forbes CD; Elias N; Cantarovich M; Cleland P; Metrakos P; Meakins JL Ann Surg; 1997 Sep; 226(3):356-65; discussion 365-8. PubMed ID: 9339942 [TBL] [Abstract][Full Text] [Related]
17. Lamivudine therapy of hepatitis B virus-related liver disease: cirrhosis, posttransplantation recurrence, and de novo infection. Bárcena R; Domínguez-Antonaya M; López-Sanromán A; Martínez-Turnes A; Urman J; del Campo S; Moreno N Transplant Proc; 1999 Sep; 31(6):2457-8. PubMed ID: 10500669 [No Abstract] [Full Text] [Related]
18. Stem cells and hepatic cirrhosis. Chen Z; Qi LZ; Zeng R; Li HY; Dai LJ Panminerva Med; 2010 Jun; 52(2):149-65. PubMed ID: 20517197 [TBL] [Abstract][Full Text] [Related]